Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...
24/7 Wall St. on MSN
Can Apple Enjoy a “Siri Surge” as Apple Catches Up in AI?
Shares of Apple (NASDAQ:AAPL) plunged into correction territory on Thursday as the losing streak extended to a whopping seven ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...
Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...
Razer's always good for a couple of neat concepts at every CES, though they don't necessarily work well as eventual products.
Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...
News-Medical.Net on MSN
Novel approach uncovers possible drugs based on specific cellular targets for treating glioblastoma
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
16hon MSN
Commercially viable biomanufacturing: Designer yeast turns sugar into lucrative chemical 3-HP
Using a tiny, acid-tolerant yeast, scientists have demonstrated a cost-effective way to make disposable diapers, ...
CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.
Jan 5 (Reuters) - Advanced Micro Devices (AMD.O) CEO Lisa Su showed off a number of the company's AI chips on Monday at the ...
Cells spend energy not just on reactions, but on control. New research explains why staying stable comes with an unseen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results